Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

Strategic Partnerships that are Transforming the Healthcare Industry

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
29-Dec-2015
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D6C1-01-00-00-00
SKU
LS00159-GL-TR_17127
Yes
SHARE

Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology
Published on: 29-Dec-2015 | SKU: LS00159-GL-TR_17127

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized medicine, combination devices and regenerative medicine, have been the beneficiary of research and business collaborations. This research service identifies areas along the product development cycle that can be mined for collaborations, case studies of successful partnerships from the last few years, and various avenues available for stakeholders.

What You Can Expect

Research Methodology

Research Methodology (continued)

The Essence of the Research Service

Key Findings

The Need for Collaboration within Healthcare

Sources of Collaboration in the Healthcare Industry

Sources of Collaboration in the Healthcare Industry (continued)

Types of Collaborations

Collaboration by Market Segments

Next-Generation Stents

Notable Industry Collaborations

Tissue Engineered Products

Notable Industry Collaborations

Smart Drug Delivery

Notable Industry Collaborations

Companion Diagnostics

Notable Industry Partnerships

Collaboration by Market Participants

University-Led Collaborations

Government-Led Collaborations

Industry Collaborations

Research Consortia

Joint Ventures

Overview of Investor Networks

Government Funding

Venture Capital Funding

Corporate Venture Capital (CVC) Funding

Open Innovation

Call for Partnerships

Research Consortia

Technologies Available for Licensing

Technologies Available for Licensing (continued)

Technologies Available for Licensing (continued)

Top Innovation Hotspots

Top Corporate Investors

TechVision Predictions

Key Contacts

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized medicine, combination devices and regenerative medicine, have been the beneficiary of research and business collaborations. This research service identifies areas along the product development cycle that can be mined for collaborations, case studies of successful partnerships from the last few years, and various avenues available for stakeholders.
More Information
Deliverable Type Technology Research
No Index No
Podcast No
Author Bhargav Rajan
WIP Number D6C1-01-00-00-00
Is Prebook No

Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00159-GL-TR_17127